FINWIRES · TerminalLIVE
FINWIRES

在投资者会议后，Stifel Canada维持对Algoma Steel Group的“买入”评级；目标价维持在11.50加元。

By

-- 周一，Stifel Canada维持对Algoma Steel Group (ASTL.TO)股票的“买入”评级，目标价为11.50加元。此前，该公司管理层召开了投资者会议。 “我们安排了首席执行官拉贾特·马尔瓦 (Rajat Marwah) 和首席财务官迈克尔·莫拉卡 (Michael Moraca) 出席投资者会议，就公司目前的财务前景而言，我们认为会议总体上是积极的。公司正致力于转型成为加拿大钢铁产品行业的领军企业，包括新增 (1) 一座型钢轧机；以及 (2) 拓展其钢板业务。我们相信，加拿大联邦政府对国防和基础设施的投入将直接或间接地惠及公司。鉴于公司预计 2027 年的 EBITDA 仅为 3500 万美元，估值目前基本无关紧要，但 2026 年的一些催化剂可能会对这一结果产生积极影响（特别是美墨加协定谈判）。我们对公司的扭亏为盈前景依然乐观，因此维持“买入”评级和每股 11.50 美元的目标价。”分析师伊恩·吉利斯 (Ian Gillies) 写道。 （报道北美、亚洲和欧洲主要银行及研究机构的股票、商品和经济研究报告。研究机构可通过以下链接联系我们：https://www..com/contact-us）

Price: $6.34, Change: $-0.16, Percent Change: -2.46%

Related Articles

Mining & Metals

Stifel Canada Hikes Aritzia Price Target to $158.00

Stifel Canada is expecting another strong quarter from Aritzia (ATZ.TO) when it reports its fiscal fourth-quarter earnings on May 7.Analyst Martin Landry, who is raising his price target on the company's shares by $8.00 to $158.00 and maintaining a buy rating, is also hiking comparable sales growth expectation by 700bps to 21% Y/Y, higher than consensus of 18%."We expect Aritzia to introduce a FY27 guidance higher than current consensus expectations, potentially driving upwards earnings revisions," Landry adds. Aritzia shares touched an all-time high on Friday as investors are pricing the company's strong operational performance.Landry also expects earnings per share growth of 34% Y/Y in fiscal 27, higher than peers.Price: $139.87, Change: $-3.34, Percent Change: -2.33%

$ATZ.TO
Australia

HCA Healthcare Pressure Expected to Persist Through Q2 on Managed Care Rotation, RBC Says

HCA Healthcare (HCA) may face near-term pressure through at least the first half as investors rotate toward managed care, although better trends in March and in-line exchange dynamics support the longer-term outlook, RBC Capital Markets said.The company's weaker-than-expected Q1, driven by lower respiratory volume and weather-related disruption, has increased near-term concern around hospital volumes and patient mix.RBC said in a Sunday note that it expects Friday's share price decline to persist through Q2 as management works to demonstrate execution against growth targets and as investors await further clarity on the impact of ePTC expiry.The investment firm said March volumes improved meaningfully while exchange-related pressure remains manageable. HIX declines reflect both lost volume and patients in grace periods already incorporated into bad debt reserves. Surgical and outpatient trends remain broadly consistent with its full-year outlook, according to the note.RBC reiterated its outperform rating and lowered its price target to $534 from $593, citing increased caution on near-term hospital volume and mix dynamics and a broader rotation toward managed care.Price: $439.41, Change: $+6.95, Percent Change: +1.61%

$HCA
Mining & Metals

BluEnergies Announces DTC Eligibility

BluEnergies (BLU.V) shares are now eligible for electronic clearing and settlement in the United States through the Depository Trust Company (DTC), BluEnergies said on Monday.The company's shares recently began trading on the OTCQX Best Market under the ticker BLUGF, it added."Obtaining DTC eligibility marks an important step in expanding BLU's investor base and enhancing accessibility for shareholders," said chief executive Craig Steinke. "For investors, DTC eligibility is a key milestone that streamlines electronic trading and supports improved liquidity, which is especially important as we advance the development of our assets in the Harper Basin, Liberia and Gulf of America and continue to build long-term value across our portfolio."The company's shares were last seen down $0.09, or 3.1%, to $2.73 on the TSX Venture Exchange.Price: $2.73, Change: $-0.09, Percent Change: -3.19%

$BLU.V